Covered recipient · General Payments record
MARK E BASIRATMAND
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$2,460.27
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,751.06 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $517.97 | 10 |
| Amgen Inc. | $394.19 | 6 |
| ABBVIE INC. | $245.92 | 2 |
| IBSA Pharma Inc. | $216.14 | 8 |
| Esperion Therapeutics, Inc. | $151.45 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $125.00 | 1 |
| Ardelyx, Inc. | $83.32 | 3 |
| Merck Sharp & Dohme Corporation | $17.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106492904 | CMS |
| ABBVIE INC. | $120.92 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106492906 | CMS |
| Amgen Inc. | $124.99 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117198743 | CMS |
| Amgen Inc. | $125.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117502564 | CMS |
| Amgen Inc. | $13.22 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117198737 | CMS |
| Amgen Inc. | $25.92 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117198739 | CMS |
| Amgen Inc. | $84.76 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117502562 | CMS |
| Amgen Inc. | $20.30 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117198741 | CMS |
| Ardelyx, Inc. | $32.14 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146718135 | CMS |
| Ardelyx, Inc. | $24.66 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146718137 | CMS |
| Ardelyx, Inc. | $26.52 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146718139 | CMS |
| Esperion Therapeutics, Inc. | $124.83 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129462150 | CMS |
| Esperion Therapeutics, Inc. | $26.62 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129462152 | CMS |
| IBSA Pharma Inc. | $24.63 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980815 | CMS |
| IBSA Pharma Inc. | $120.30 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142977386 | CMS |
| IBSA Pharma Inc. | $23.88 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980817 | CMS |
| IBSA Pharma Inc. | $18.94 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980819 | CMS |
| IBSA Pharma Inc. | $0.36 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980821 | CMS |
| IBSA Pharma Inc. | $4.66 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980823 | CMS |
| IBSA Pharma Inc. | $17.80 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980825 | CMS |
| IBSA Pharma Inc. | $5.57 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980827 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $125.00 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153740218 | CMS |
| Merck Sharp & Dohme LLC | $17.07 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141570736 | CMS |
| Novo Nordisk Inc | $23.41 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588011 | CMS |
| Novo Nordisk Inc | $19.30 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100513385 | CMS |
| Novo Nordisk Inc | $121.83 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100468844 | CMS |
| Novo Nordisk Inc | $19.24 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100642848 | CMS |
| Novo Nordisk Inc | $124.39 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100460054 | CMS |
| Novo Nordisk Inc | $31.25 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100458838 | CMS |
| Novo Nordisk Inc | $20.08 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100600741 | CMS |
| Novo Nordisk Inc | $10.87 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100416260 | CMS |
| Novo Nordisk Inc | $125.00 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100294944 | CMS |
| Novo Nordisk Inc | $22.60 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100505885 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.